Results 181 to 190 of about 11,212 (232)
Some of the next articles are maybe not open access.
Prognosis of ocular myasthenia
Annals of Neurology, 1983AbstractA retrospective study of 108 patients with myasthenia gravis who had solely ocular symptoms and signs at onset was carried out to identify factors influencing prognosis. Increasing duration of pure ocular myasthenia was associated with a decreasing risk of late generalized symptoms; only 9 (15%) of the observed generalizations occurred after ...
C T, Bever +4 more
openaire +2 more sources
Neurology, 1981
Three patients with ocular myasthenia in childhood experienced complete and prolonged remissions lasting 4 to 14 years and then suffered recurrences of ocular myasthenia. One had another spontaneous remission and then relapsed again. All were subsequently in remission on oral steroid medication.
R D, Rollinson, G M, Fenichel
openaire +2 more sources
Three patients with ocular myasthenia in childhood experienced complete and prolonged remissions lasting 4 to 14 years and then suffered recurrences of ocular myasthenia. One had another spontaneous remission and then relapsed again. All were subsequently in remission on oral steroid medication.
R D, Rollinson, G M, Fenichel
openaire +2 more sources
Current Treatment Options in Neurology, 2005
Myasthenia gravis (MG) is an autoimmune disorder characterized clinically by proximal weakness and bulbar symptoms and pathologically by damage to the post-synaptic membrane at the neuromuscular junction. Ocular myasthenia gravis (ocular MG) is a form of myasthenia gravis whereby the patients' weakness is limited to the muscles of the eyes and eyelids (
Neil C, Porter, Brian C, Salter
openaire +2 more sources
Myasthenia gravis (MG) is an autoimmune disorder characterized clinically by proximal weakness and bulbar symptoms and pathologically by damage to the post-synaptic membrane at the neuromuscular junction. Ocular myasthenia gravis (ocular MG) is a form of myasthenia gravis whereby the patients' weakness is limited to the muscles of the eyes and eyelids (
Neil C, Porter, Brian C, Salter
openaire +2 more sources
Current Treatment Options in Neurology, 2001
Treatment decisions for ocular myasthenia gravis (OMG) should be based on symptomatology. Local, nonpharmacologic treatment of ptosis or diplopia is successful in relatively few patients, and the majority of patients require drug therapy for satisfactory resolution of their symptoms.
Victoria S., Pelak, Steven L., Galetta
openaire +2 more sources
Treatment decisions for ocular myasthenia gravis (OMG) should be based on symptomatology. Local, nonpharmacologic treatment of ptosis or diplopia is successful in relatively few patients, and the majority of patients require drug therapy for satisfactory resolution of their symptoms.
Victoria S., Pelak, Steven L., Galetta
openaire +2 more sources
Ophthalmology Clinics of North America, 2004
Myasthenia gravis may be limited solely to the eyes (ocular myasthenia) or may have systemic manifestations (generalized myasthenia). Most patients display blepharoptosis or ophthalmoparesis, resulting in diplopia, but the ocular motility disorder may take many forms. The diagnosis is often elucidated by variable muscle weakness with fatigability noted
Rachael D, Elrod, David A, Weinberg
openaire +2 more sources
Myasthenia gravis may be limited solely to the eyes (ocular myasthenia) or may have systemic manifestations (generalized myasthenia). Most patients display blepharoptosis or ophthalmoparesis, resulting in diplopia, but the ocular motility disorder may take many forms. The diagnosis is often elucidated by variable muscle weakness with fatigability noted
Rachael D, Elrod, David A, Weinberg
openaire +2 more sources
Ocular myasthenia and nitrofurantoin
American Journal of Ophthalmology, 2000To report a case of ocular myasthenia associated with administration of nitrofurantoin.Case report and review of the literature.While taking nitrofurantoin after urinary tract surgery, a 10-year-old female developed diplopia and ptosis. Sleep test confirmed ocular myasthenia.
B N, Wasserman +3 more
openaire +2 more sources
Current Opinion in Ophthalmology, 2012
To review ocular myasthenia gravis (OMG), a localized form of myasthenia gravis clinically involving only the extraocular, levator palpebrae superioris, and orbicularis oculi muscles.Ocular manifestations can masquerade as a variety of ocular motility disorders, including central nervous system disorders and peripheral cranial nerve palsies.
Michael S, Vaphiades +2 more
openaire +2 more sources
To review ocular myasthenia gravis (OMG), a localized form of myasthenia gravis clinically involving only the extraocular, levator palpebrae superioris, and orbicularis oculi muscles.Ocular manifestations can masquerade as a variety of ocular motility disorders, including central nervous system disorders and peripheral cranial nerve palsies.
Michael S, Vaphiades +2 more
openaire +2 more sources
The Neurologist, 2006
Although myasthenia gravis (MG) is often considered the best-understood autoimmune disorder and effective treatments have controlled life-threatening complications, the pathogenesis of ocular myasthenia (OM) remains enigmatic, and its clinical consequences offer therapeutic challenges.About half of patients with MG present with visual complaints of ...
Linda L, Kusner +2 more
openaire +2 more sources
Although myasthenia gravis (MG) is often considered the best-understood autoimmune disorder and effective treatments have controlled life-threatening complications, the pathogenesis of ocular myasthenia (OM) remains enigmatic, and its clinical consequences offer therapeutic challenges.About half of patients with MG present with visual complaints of ...
Linda L, Kusner +2 more
openaire +2 more sources
Russian Annals of Ophthalmology
Myasthenia gravis is an autoimmune disease characterized by muscle weakness and pathological fatigue due to autoaggressive phenomena with the formation of antibodies directed against various structures of the neuromuscular synapse. In most patients, the disease begins with the involvement of extraocular muscles, presenting with symptoms such as ...
M.S. Sergeeva +2 more
openaire +3 more sources
Myasthenia gravis is an autoimmune disease characterized by muscle weakness and pathological fatigue due to autoaggressive phenomena with the formation of antibodies directed against various structures of the neuromuscular synapse. In most patients, the disease begins with the involvement of extraocular muscles, presenting with symptoms such as ...
M.S. Sergeeva +2 more
openaire +3 more sources
Update on Ocular Myasthenia Gravis
Neurologic Clinics, 2017Ocular myasthenia gravis (OMG) is a localized form of myasthenia gravis in which autoantibodies directed against acetylcholine receptors block or destroy these receptors at the postsynaptic neuromuscular junction. The hallmark of OMG is a history of painless weakness or fatigability of the extraocular muscles and ptosis with normal pupillary function ...
Stacy V, Smith, Andrew G, Lee
openaire +2 more sources